Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Name: Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
License: Public Domain

Hua Zhang

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

unresectable non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 432890
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.